Safe, Effective Prescribing for a Lifetime
Diagnoses expand. Medications change. Patients age. Polypharmacy increases.
Genomind stays clinically relevant as life changes.
DOB: 5/21/1964
Lipitor
OUTCOME
Potential increase in LIPITOR serum levels: May require lower doses
Toprol
Powered by genetic intelligence.
GenMedPro is the leading genetics-based medication management solution that embeds demographics, drug-drug and gene-drug interactions, and social determinants of health within a single platform that can be utilized across the life of a patient.
More clinical depth, better for polypharmacy, and insights for a lifetime. That’s GenMedPro.
A holistic PGx platform built for the complexity of real-world prescribing.
Developed to work best with Genomind’s PGx test, GenMedPro analyzes 26 genes that impact commonly prescribed medications across a variety of specialties.
This matters in real practice—because patients are rarely on just one medication for one condition. Without a complete picture of the patient’s medications and genetic impact, providers are flying blind.
A science-based second opinion... first.
Whether supporting individual prescribers or large populations, GenMedPro delivers consistent, evidence-based medication intelligence that scales across care settings.
Smarter Prescribing
GenMedPro identifies significant genetic and drug interactions upfront—helping prevent adverse events and avoid unnecessary ED visits or hospital stays that drive up total cost of care.
Better Outcomes
By surfacing polypharmacy risks in a single view, GenMedPro helps providers reduce trial-and-error prescribing and medication waste. Providers often de-prescribe away from ineffective (or harmful) prescriptions.
PGx Simplified
GenMedPro integrates advanced PGx data into everyday workflows, helping clinicians deliver safer, more effective care—without increasing visit time, staffing costs, or operational complexity.
Superior clinical utility at every stage of care.
Other PGx vendors deliver a static report isolated only to gene-drug interactions. But patients rarely take a single medication. As complexity increases, static PGx results underperform and can become unsafe.
GenMedPro extends the clinical utility of PGx testing, refreshing drug-drug and gene-drug interactions at anytime as new diagnoses emerge and medications are updated.
OUTCOME
OUTCOME
OUTCOME
The future of precision medicine.
GenMedPro is a genetics-based medication management platform for care teams to quickly evaluate prescribing options at any time, for current and future medications.
GenMedPro assesses drug-drug and drug-drug interactions to enable providers to adjust prescriptions based on critical genetic insights. With over 1,200 drugs–representing more than 99% of the most common prescriptions–Genomind is the leader in holistic genetics.
No other platform compares.
Genomind has been a game changer in the field of pharmacogenetics. No other testing company compares when it comes to educating providers and patients.
Len Getz
DNP-PMH, MSN, FNP-BC